Shares of CME Group Inc. Cl A CME shed 1.54% to $261.48 Wednesday, on what proved to be an all-around great trading session ...

CME Group Inc. Cl A closed 2.87% below its 52-week high of $273.42, which the company reached on April 4th.

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In the 'long' context, investors will be essentially be "buying high, but hoping to sell even ...

There’s a lot to be optimistic about in the Financial sector as 3 analysts just weighed in on CME Group (CME – Research Report), First Bank ...

CME Group's first-quarter earnings fell short due to rising operational expenses, mainly from technology investments, despite ...

CME Group (CME) reported $1.64 billion in revenue for the quarter ended March 2025, representing a year-over-year increase of 10.4%. EPS of $2.80 for the same period compares to $2.50 a year ago. The ...

The upcoming report from CME ... stock. Numerous empirical studies consistently demonstrate a strong relationship between trends in earnings estimate revision and the short-term price performance ...

With an impressive ROE of 3.16%, the company demonstrates effective use of equity capital and strong financial performance. Return on Assets (ROA): CME Group's ROA lags behind industry averages ...

Other equities research analysts have also issued research reports about the stock. Oppenheimer raised their target price on shares of CME Group from $258.00 to $269.00 and gave the stock an ...

CME's stock price is considered in the final part ... and rate per contract (RPC), two important indicators for evaluating CME Group's performance. For the fourth quarter of 2024, CME Group ...

CME Group is a high-margin ... business relationship with any company whose stock is mentioned in this article. Seeking Alpha's Disclosure: Past performance is no guarantee of future results.